Zusammenfassung
Autologous transplantation in de novo AML may provide us with some clues to the nature of leukemogenesis. The present study used for the first time positively selected CD34+ cells from leukapheresis products (<0.1% minimal residual disease by FACS analysis) collected during first complete remission (CR) of de novo AML (n = 43) following double induction or consolidation according AMLCG ...
